Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.21.2
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Computation of earnings per share
               
    For the Three Months Ended June 30,  
(In thousands, except per share data)   2021     2020  
Numerator:                
Loss from continuing operations   $ (1,098 )   $ (709 )
Income from discontinued operations           949  
Net income (loss)   $ (1,098 )   $ 240  
                 
Denominator:                
Weighted-average number of common shares outstanding: basic     2,093       1,839  
Weighted-average number of commons shares outstanding: diluted     2,093       1,843  
                 
Net income (loss) per share - basic                
Loss per share from continuing operations   $ (0.52 )   $ (0.39 )
Income per share from discontinued operations           0.52  
Net income (loss) per share   $ (0.52 )   $ 0.13  
Net income (loss) per share - diluted                
Loss per share from continuing operations   $ (0.52 )   $ (0.38 )
Income per share from discontinued operations           0.51  
Net income (loss) per share   $ (0.52 )   $ 0.13  
Schedule of antidilutive shares
           
    June 30,  
    2021     2020  
Common stock to be issued upon vesting of restricted stock units     1,000       5,000  
Common stock to be issued upon exercise of options     254,000       252,000  
Common stock to be issued upon exercise of warrants     119,000       169,000  
Common stock to be issued upon exercise of common stock units (1)     46,000       46,000  
      420,000       472,000  

 

(1) Consists of 30,668 restricted stock units and warrants to purchase 15,332 shares of common stock
Disaggregated Revenue by Source
           
    Three Months Ended June 30,  
Product   2021     2020  
Human Care   $ 2,715,000     $ 5,377,000  
Animal Care     812,000       377,000  
Service and Royalty     157,000       13,000  
Total   $ 3,684,000     $ 5,767,000